论文部分内容阅读
异搏停对慢性稳定型心绞痛病人的疗效虽已得到证实,但大多数试验的观察时间少于4～6周.为此,本文在63例稳定型和不稳定心绞痛病人中先比较异搏停与心得安或安慰剂短期双盲临床试用的结果,接着用异搏停治疗至少一年,并进行主观和客观的临床评价,旨在探讨异搏停在缺血性心脏病病人中长期治疗的价值.稳定型心绞痛:66例稳定型心绞痛病人,每周至少发作心绞痛2次,活动平板运动试验示ST段压低至少1毫米.患者先作异搏停与安慰剂或心得安的双盲交叉临床试用,分别交叉服用异搏停(240～
Although verapamil in patients with chronic stable angina pectoris has been confirmed, but most of the test observation time is less than 4 to 6 weeks.To this end, 63 cases of stable and unstable angina patients compared verapamil And placebo or prophylactic short-term double-blind clinical trial results, followed by treatment with verapamil for at least one year, and subjective and objective clinical evaluation, to explore the risk of ischemic heart disease in patients with long-term treatment Value Stable angina pectoris: 66 patients with stable angina pectoris had angina pectoris at least 2 times per week, and an active treadmill exercise test showed a ST depression of at least 1 mm.The patients were treated with a double-blind clinical trial of verapamil and placebo or propofol Trial, respectively, taking cross-stroke (240 ~